News

Filter

Current filters:

Anti-viralsLupin

Mixed US court decision on ViiV Healthcare’s Epzicom and Trizivir patents

19-12-2013

UK pharma giant GlaxoSmithKline and ViiV Healthcare confirmed that the US District Court for the District…

Anti-viralsEpzicomGenericsGlaxoSmithKlineLegalLupinPatentsTeva Pharmaceutical IndustriesTrizivirViiV Healthcare

Lupin may invest $50 million in Russian plant; Indian drugmakers doing well with ARVs

11-02-2011

Indian drugmaker Lupin, is considering investing up to $50 million in the construction of a plant as…

Anti-viralsAsia-PacificAurobindo PharmaCiplaEuropeFinancialHetero GroupLupinPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top